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Abstract
Introduction. Some patients used banana to administered tablet or pill . It is possible that there
will be pharmaceutical interaction between the drug and banana. This study was aimed to know the
influence of pre-treatment and co-treatment of ambon banana fruit juice (Musa paradisiaca L.) on
the furosemide bioavailability..
Method. This study was carried out using cross over design.. The subjects used in this study
were five local male rabbit with same in body weight and divided into 4 treatments. The A group was
treated by furosemide 80 mg (control), The B group was treated by ambon banana fruit juice 100% (5
ml) 2 hours before furosemide administration. The C and D groups were treated by ambon banana
fruit juice 100% and 50% (5 ml) in the same time with furosemide administration. The blood was
taken through marginalis vein of ears at the time 0,5; 0,75; 1; 1,5; 2; 3; 3,5; 4; 8; and 24 hours after
furosemide administration. Furosemide in the blood was determined using Kelly’s method modified
by Hakim. Then, the bioavailability parameters were measured from pharmacokinethics profiles .
Furthermore, t max and Cp max were analized using one-way Anova while AUC0-8 was analized
using Kruskal-wallis.
Result. The average of furosemide bioavailability in male rabbit are Cpmax ; 15,21.10-2
(ìg/ml), 13,97.10-2 (ìg/ml), 11,08.10-2 (ìg/ml), 12,10.10-2 (ìg/ml), tmax; 2,30 hours, 3,50 hours, 3,35
hours , 5,30 hours, and AUC0-8 ; 10,53 ìg.ml-1 hour, 4,00 ìg.ml-1 hour, 4,95 ìg.ml-1 hour, 3,37
ìg.ml-1 hour respectively for treatment A,B,C, and D. There were no significant differences of tmax
and Cpmax and AUC0-8 among groups ( p value> 0.05).
Conclusion. There were no influence of pre-tretment and co-treatment of ambon banana fruit
juice (Musa paradisiaca L.) on the furosemide bioavailability.
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INTRODUCTION
Peroral administration is the most natural
administration of the medicines. Most of the
peroral dosage forms such as tablets, capsules,
pills, should be swallowed with water. However,
some patients can not take their per oral
medication without bananas. This could
becaused by the physical properties of the
banana fruit is soft and pliant so that it can help
patients in swallowing the medicine. The use of
bananas along with the drug is not only found in
homes, but also at the hospital. Patients who need
banana to take the medicines generally those
who are elderly, children and patients who have
difficulty swallowing medication with water.
The habit of medicine administration along with
banana could be a problem, because the presence
of food-drug interactions. We could not
understand the abnormalities or changes of our
body, because of the the light effects of
drug-food interaction. However, people consider
banana in this issue because it was easy to obtain,
the price is also accessible by the whole society
(Handayani,2009).
The prevalence of hypertension in
Indonesia reached 31.7% of the population at the
age of 18 years and over 60% of them were
ended in stroke. While the rest were ended by
heart, kidney failure and blindness.
According to Joint National Committee (JNC) 7,
the first line therapy for hypertension is a
diuretic, one furosemida. The Biopharmaceutics
Drug Classification System (BCS) categorizes
furosemida as class II, due to low solubility,
furthermore furosemida also has a 95% protein
binding (McEvoy, 2002), thus furosemide is
potential for interacting with other agents.
According to the premise that people often
take the medicine with a green banana, including
furosemide allows the interaction between them.
Theoretically, consumption of bananas along
with the favorable interaction furosemide is
because bananas contain lots of potassium
(Anonymous, 2002), whereas a loop diuretic is
likely causes hypokalemia. The
co-administration with banana juice could be
expected to affect the bioavailability of the
furosemide tablet. The aim of this study was to
evaluate the effect of pre-treatment and
co-treatment of ambon banana fruit juice (Musa
paradisiaca L.) on the furosemide
bioavailability.
MATERIALS AND METHODS
MATERIALS
The instruments used in this study were:
glass tools, scapel, micro pipettes, syringes,
vortex (Thermolyne 37 600), centrifuge
equipment (centrifuges) Mettler Toledo AG 285,
spectrofluorometer (Hitachi F 2500) and
analytical balance (CEN Phoenix 91 501).
The materials used were obtained from the
ambon banana one supermarket in the city of
Yogyakarta. The chemicals used were of
pharmaceutical furosemide degrees (Indofarma),
ethyl acetate pa (E Merck), HCl pa (E Merck),
phosphate buffer pH 8, NaOH pa, heparin,
distilled water (Lab Asia) and the local strain
male rabbits aged 3 months with the same
weight.
Identification and Preparation of Ambon
Banana Fruit Juice
Identification of plant was performed at
the Laboratory of Biology, University Ahmad
Dahlan. Identification was done in an
organoleptic, based on physical characteristics,
odor, color and distinctive flavor of banana fruit.
Banana juice was made by weighing 50 g of
bananas and water to 50 ml. The concentration of
50% w / v was obtained by the dilution of 100%
w / v.
Bioavailability Furosemida Parameter
Determination in Blood
The five same weight of local strain male
rabbits were examined using Cross Over design
with 4 treatments (Table I).
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Before the treatment, the rabbits were
fasted for one day. We consider 7 days for
washing out in each treatment. After the drug
administration, the blood was taken at hours 0.5,
0.75, 1, 1.5, 2; 2.5; 3; 4; 8 and 24, through the
vena marginalis rabbit ears. The blood as
collected in tubes with heparin ependrof.
Determination of the furosemida
bioavailability
The bioavailability parameters included in
this study were Cp max, t max and AUC 0-8
which were obtained directly from the
relationship curve between drug concentration
and time, and AUC 0-8 was obtained by the
trapezoidal method.
DATA ANALYSIS
Data were analyzed statistically with tests
of homogeneity of variance and data normality.
After considering the homogeneity of variance
and data normality the differences between the
treatments were analyzed using or Kruskal
Wallis test.
RESULTS AND DISCUSSION
This study showed that there were no
influence of pre-treatment and co-treatment of
ambon banana fruit juice (Musa paradisiaca L.)
on the furosemide bioavailability.
PLANT IDENTIFICATION
The ambon banana used in this study was
white when ripe yellow discharge. Its skin was
smooth and would change the color into yellow
when ripe at room temperature. Taste slightly
sour was sweet and strong odor. These bananas
have an average length of 15-20 cm and a
diameter of 3.5 to 4 cm (Anonymous, 2010). The
banana is creamy colored, fragrant and sweet
(Anonymous, 2011 ).
From the determination of the excitation
and emission wavelengths in the blood plasma,
furosemide was consecuted at 272 nm and 404
nm, whereas the linear regression equation for
the standard curve was: Y = 0.247 + 4.767 x; r =
0.996.
Recovery requirements analysis method
that is between 80-120% of the levels was listed
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Rabits
Week
I II III IV
1 A B C D
2 B C D C
3 C D A B
4 D A B A
5 A B C D
A = 80 mg tablet furosemide (control), B = Pretreatment of 100% w / v banana juice 2 h before the furosemida tablet, C =
Co-treatment of 100% w / v banana juice with a furosemida tablet, D = Co-treatment of 50% w / v banana juice with a
furosemide tablet, The total volume of solution was 5 ml
Table I. Cross over the design and treatment with banana juice on the bioavailability of the furosemide tablet
Figure 1. Ambon banana fruit
in the table (FDA requirements) (Pusporini,
2006). The recovery ranges from 89.96 to
107.28% indicated that the method chosen has
accurate range of % recovery (% recovery.
The smallest percent degradation of furosemide
was found when it was stored at -20 ° (freezer),
thus, the sample should be directly extracted the
plasma stored in the freezer.
Table II and Figure 3 are presented the
furosemide concentration in blood plasma.
Next, the bioavailability of furosemide tablet on
male rabbits are shown in Table III.
After the calculation, the obtained
parameters such as bioavailability of the
furosemide tablet are presented in table III
There were no significant differences in
bioavailability parameters among 4 treatments.
The results showed that the bioavailability
parameter in each treatment produced no
significant differences (p> 0.05) both at AUC, t
max and Cp max. This means that treatment the
banana juice did not influence furosemide
bioavailability significantly. There was also no
significant differences of furosemide
bioavailability in the co-treatment of 5 ml banana
juice at a concentration of 50% w / v to 100% w /
v with furosemide tablet. There were no
significant differences of tmax and Cpmax and
AUC0-8 among groups ( p value> 0.05).
The results are consistent with the study
performed by Kelly et al (1974) and
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Time
(hours)
C(g/ml)
A
mean±SE (10-2)
B
mean±SE (10-2)
C
mean±SE (10-2)
D
mean±SE (10-2)
0 0 0 0 0
0,5 4,70 ± 0,88 4,01 ± 0,48 5,53 ± 0,66 6,44 ± 2,13
0,75 5,06 ± 0,83 4,39 ± 1,23 5,49 ± 1,68 5,18 ± 1,25
1 8,03 ± 2,41 4,18 ± 1,04 4,11 ± 0,71 6,81 ± 2,15
1,5 10,14 ± 5,52 7,35 ± 2,33 4,73 ± 1,20 9,34 ± 2,01
2 12,69 ± 5,04 10,78 ± 3,43 5,79 ± 1,48 6,07 ± 1,08
2,5 9,57 ± 2,09 6,23 ± 2,17 6,72 ± 1,95 8,07 ± 1,81
3 8,27 ± 1,32 9,88 ± 1,46 7,27 ± 2,37 11,12 ± 2,43
4 8,14 ± 1,46 8,14 ± 2,00 10,61 ± 2,51 8,94 ± 2,08
8 6,31 ± 1,34 7,83 ± 2,35 8,61 ± 2,68 9,06 ± 2,30
24 5,69 ± 0,93 5,15 ± 1,36 6,19 ± 1,44 4,31 ± 1,49
Table II. Furosemide levels in blood plasma vs time (mean ± SE) on treatment with banana juice
Figure 2. Curve levels furosemide (mean ± SE) in plasma
vs time. The 80 mg of furosemide tablet was given orally
Hammurland et al (1982) which stated that
furosemide provided with food did not affect the
bioavailability of the drug, although
Hammurland et al found that the peak levels
decreased and the study of food provided is not
mentioned specifically. These results were in
contrast to the results obtained by Beermann
(1986) which stated that food may decrease the
bioavailability of furosemide about 30%, but the
decreased bioavailability due to the diuretic
effect furosemide not because of the interaction
with food intake. The research was conducted on
healthy humans with food such as milk, cheese,
egg, avocado and fish juice. According
McCrandle, et al (1996) furosemida 40 mg
supplied with food (orange juice, eggs, milk and
butter) were also significantly reduce the
bioavailability of 30% but decreased
bioavailability of the mechanism is not described
further. This study has limitations in the
sensitivities analysis methods are used, so for
further research are expected to use more
sensitive analytical methods, eg HPLC.
CONCLUSION
1. Pre-tretment of banana juice did not affect the
bioavailability of the tablet furosemide
parameters (p>0.05).
2. There weres no significant difference of
furosemide bioavailability in the effect of 5
ml banana juice co treatment at a
concentration of 50% w / v to 100% w / v.
3. There was no significant difference in the
effect of giving 5 ml banana juice 100% w / v
simultaneously or two hours prior to the
furosemide bioavailability
REFERENCE
Anonim, 2002, AHFS Drug Information, Book 5,
2566-2570, American Society of
Health-System Pharmacists, USA.
Beermann, B., Midskow, C., 1986, Reduce
Bioavailability and Effect of Furosemide
Given with Food, J Clin.Pharmacol,
29:725-727
Chobanian, A.V., Bakris, G.L., BLACK, H.R.,
Green, L,A., dan Joseph, L.L., 2003, The
Sevent Report of Joint National
Commetee VII on Preventation,
Detection, Evaluation, and Treatment of
Hight Blood Preasure,
http/www.jasa-ama-assn
org/cgi/content/full/289.19.256 Vi,
accessed on 16 April 2008
Hakim, L., 1996, Ekskresi Urin Furosemida pada
Kelinci setelah Praperlakuan dengan
bunga kubis, Laporan penelitian,
Universitas Gadjah Mada, Yogyakarta.
Hammurlund, MM., Paalzow LK., Odlind B.,
Pharmacokinetics of Furosemide in man
after intravenous and oral administration,
Application of moment analysis,
Clin.Pharmacol. Ther.,1983;25:197-207.
Jehan, N., 2005, Uji Efek Infusa Daun Teh
(Camelia sinensis (L.) O.K. folium) pada
Tikus Putih Jantan Galur Wistar, skripsi,
Proceeding of International Conference on Drug Development of Natural Resources 30 Juni 2012 5
ISBN : 978-979-18458-4-7
Parameters
Treatment
A B C D
Mean ± SE Mean ± SE Mean ± SE Mean ± SE
Cpmax (g/ml) 15,21 ± 4,67 13,97 ± 2,62 11,08 ± 2,51 12,10 ± 2,24
tmax (Jam) 2,30 ± 0,62 3,50 ± 1,16 3,35 ± 0,65 5,30 ± 1,10
AUC0- (g/ml.
hours)
10,53 ± 5,67 4,00 ± 1,15 4,95 ± 1,08 3,37 ± 1,29
Table III. The mean parameter furosemide tablet bioavailability in banana juice treatment
Fakultas Farmasi Universitas Ahmad
Dahlan, Yogyakarta.
Kelly, M.R., Cutler, R.E, Forrey, A.W., and
Kimpel, B.M., 1974, Pharmacokinetics of
orally Administered Furosemid, J
Clin.Pharmacol. Ther., 15:178-186.
Mayershon, M., 1996, in Prinsiples of Drug
Absorption in: Banker, G.S., and Rhodes,
C.T., (Ed.), Modern Pharmaceutics, 3th
ed, 122-125, Marcel Dekker Inc., New
York,
McCrandle, J.L., Li kam wa, T.C., Barron, W.,
Prescott, L.F., 1996, Effect of food on the
Absorption of Frusemide and
Bumentanide in Man, J Clin.Pharmacol,
42:743-746
Mutschler, E., 1991, Dinamika Obat,
diterjemahkan oleh Mathilda, B.W, dan
Anna, S.R., 5th ed, 9-12, 93, 572, Penerbit
ITB, Bandung.
Shargel, L, Wu-Pong., and Yu, A.B.C., 2005,
Applied Biopharmaceutics and
Pharmacokinetics, 5th Edition, 375-382,
453, 457-458, 460-461, The McGraw-Hill
Companies, Inc, Singapore.
6 Proceeding of International Conference on Drug Development of Natural Resources 30 Juni 2012
ISBN : 978-979-18458-4-7
